Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms
Completed · Phase 2 · Has a placebo group
Conditions studied: Schizophrenia and Predominant Negative Symptoms
In brief
To explore the efficacy of SPD489, as adjunctive therapy to a stable dose of atypical antipsychotic medication, on negative symptoms in adult subjects with clinically stable schizophrenia and predominant negative symptoms, as measured by the Scale for the Assessment of Negative Symptoms (SANS).
Key facts
- Study ID
- NCT00922272
- Run by
- Shire
- People needed
- 92
- Starts
- 2009-09-14
- Expected to finish
- 2011-01-20
- Last updated by the study team
- 2021-06-09
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults aged 18-55
- Clinically stable Schizophrenia and predominant negative symptoms
- Taking a stable dose of antipsychotic medication
You may not qualify if…
- Clinically notable positive symptoms defined by PANSS
Where it is running
- K&S Professional Research Services — Little Rock, Arkansas, United States
- South Coast Clinical Trials — Anaheim, California, United States
- Omega Clinical Trials — Anaheim, California, United States
- Clinical Innovations — Costa Mesa, California, United States
- Collaborative Neuroscience Network, Inc. — Garden Grove, California, United States
- Apostle Clinical Trials, Inc. — Long Beach, California, United States
- Excell Research, Inc. — Oceanside, California, United States
- Southcoast Clinical Trials — San Bernardino, California, United States
- CNRI San Diego & Los Angeles — San Diego, California, United States
- Affiliated Research Institute — San Diego, California, United States
- Artemis Institute for Clinical Research — San Diego, California, United States
- Neuropsychiatric Research Center of Orange County — Santa Ana, California, United States
- Accurate Clinical Trials — Kissimmee, Florida, United States
- Behavioral Clinical Research, INC — Lauderhill, Florida, United States
- Segal Institute for Clinical Research (Miami) — North Miami, Florida, United States
- Medical Research Group of Central Florida — Orange City, Florida, United States
- Stedman Clinical Trials — Tampa, Florida, United States
- Comprehensive NeuroScience — Atlanta, Georgia, United States
- Uptown Research Institute — Chicago, Illinois, United States
- J. Gary Booker, MD, APMC — Shreveport, Louisiana, United States
- CRI Worldwide, LLC. — Willingboro, New Jersey, United States
- Advanced Bio-Behavioral Sciences — Elmsford, New York, United States
- Comprehensive Neuroscience, Inc. — Hollis, New York, United States
- University of Cincinnati — Cincinnati, Ohio, United States
- CRI Worldwide — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.